Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Benzodiazepine DependenceOpioid Dependence
Interventions
DRUG

Gabapentin

For the first week, one 400 mg Gabapentin capsule taken 3 times per day. For the second week, two 400 mg Gabapentin capsules taken 3 times per day. For the third week through the eighth week, three 400 mg Gabapentin capsules taken 3 times per day. For the ninth and last week, two 400 mg Gabapentin capsules taken 3 times per day for 3 days, then one 400 mg Gabapentin capsule taken 3 times per day for 4 days. Placebo study medication appears identical to active medication and is prescribed with an identical dosing schedule.

DRUG

Placebo

placebo comparator appears identical to active medication and is prescribed with an identical dosing schedule with a maximum dose of 400mg taken three times per day

Trial Locations (1)

11101

Bridge Plaza Treatment and Rehabilitation Clinic, Long Island City

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00420771 - Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients | Biotech Hunter | Biotech Hunter